Sanofi Consumer Healthcare India Ltd Quarterly Results: Standalone & Consolidated Reports

Quarterly Results

Results Snapshot

YoYQoQ

Figures in Cr

Standalone Quarterly Results

Sep'25

Jun'25

Mar'25

Dec'24

Sep'24

Jun'24

Mar'24

Quarterly Analysis Highlights - QoQ

Net Sales

QoQ Growth in quarter ended Sep 2025 is 5.89% vs 27.98% in Jun 2025

Standalone Net Profit

QoQ Growth in quarter ended Sep 2025 is 3.62% vs 21.40% in Jun 2025

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Sep 2025 is 21.08% vs 9.69% in Jun 2025

Interest

QoQ Growth in quarter ended Sep 2025 is 20.00% vs 25.00% in Jun 2025

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025

Compare Quarterly Results Of Sanofi Consumer With

Select Peers

Figures in Cr

Standalone Quarterly Results

Change(INR)

Change(%)

Net Sales

233.90

587.98

-354.08

-60.22%

Other Operating Income

0.00

Total Operating income

233.90

587.98

-354.08

-60.22%

Raw Material Cost

36.50

288.96

-252.46

-87.37%

Purchase of Finished goods

26.00

0.00

26.00

(Increase) / Decrease In Stocks

-0.70

-40.04

39.34

98.25%

Employee Cost

31.70

66.40

-34.70

-52.26%

Power Cost

0.00

Manufacturing Expenses

0.00

Selling and Distribution Expenses

0.00

Other Expenses

55.40

93.49

-38.09

-40.74%

Total Expenditure (Excl Depreciation)

148.90

408.81

-259.91

-63.58%

Operating Profit (PBDIT) excl Other Income

85.00

179.17

-94.17

-52.56%

Other Income

3.00

14.72

-11.72

-79.62%

Operating Profit (PBDIT)

88.00

193.89

-105.89

-54.61%

Interest

0.60

1.32

-0.72

-54.55%

Exceptional Items

0.00

Gross Profit (PBDT)

87.40

192.57

-105.17

-54.61%

Depreciation

3.30

18.44

-15.14

-82.10%

Profit Before Tax

84.10

174.14

-90.04

-51.71%

Tax

21.20

44.11

-22.91

-51.94%

Provisions and contingencies

0.00

Profit After Tax

62.90

130.03

-67.13

-51.63%

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

62.90

130.03

-67.13

-51.63%

Equity Capital

23.00

25.43

-2.43

-9.56%

Face Value

10.00

2.00

0.00

Reserves

0.00

Earnings per share (EPS)

27.35

10.23

17.12

167.35%

Diluted Earnings per share

27.31

10.60

16.71

157.64%

Operating Profit Margin (Excl OI)

36.34%

30.47%

0.00

5.87%

Gross Profit Margin

37.37%

32.75%

0.00

4.62%

PAT Margin

26.89%

22.11%

0.00

4.78%

Public Share Holdings (%)

0.00%

0.00

0.00%

Pledged Promotor Holding (%)

0.00%

0.00

0.00%

Quarterly - Net Sales

Net Sales 233.90 Cr

in Sep 2025

Figures in Cr

QoQ Growth in quarter ended Sep 2025 is 5.89% vs 27.98% in Jun 2025

YoY Growth in quarter ended Sep 2025 is 46.28% vs -23.97% in Sep 2024

Quarterly - Standalone Net Profit

Standalone Net Profit 62.90 Cr

in Sep 2025

Figures in Cr

QoQ Growth in quarter ended Sep 2025 is 3.62% vs 21.40% in Jun 2025

YoY Growth in quarter ended Sep 2025 is 39.78% vs -36.80% in Sep 2024

Quarterly - Operating Profit (PBDIT)

Operating Profit (PBDIT) 85.00 Cr

in Sep 2025

Figures in Cr

QoQ Growth in quarter ended Sep 2025 is 21.08% vs 9.69% in Jun 2025

YoY Growth in quarter ended Sep 2025 is 34.71% vs -33.30% in Sep 2024

Quarterly - Interest

Interest 0.60 Cr

in Sep 2025

Figures in Cr

QoQ Growth in quarter ended Sep 2025 is 20.00% vs 25.00% in Jun 2025

YoY Growth in quarter ended Sep 2025 is -82.35% vs 0.00% in Sep 2024

Quarterly - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 36.34%

in Sep 2025

Figures in %

QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025

YoY Growth in quarter ended Sep 2025 has fallen from Sep 2024